CIDtech is dedicated to meet your needs for advanced custom synthesis on the scale of milligrams to a few kilograms.
Many of North America's leading pharmaceutical and biotech companies have come to rely on us because of:
- Skilled synthetic organic chemists with a broad range of expertise in problem solving and consulting.
- Broad experience in designing and synthesizing complex organic compounds including starting materials, advanced intermediates for API, drug standards, impurity standards, reference standards, drug metabolites (known or putative), combinatorial building blocks (platform molecules), chiral compounds and structural isomers.
- Extensive experience in 1-18 step syntheses of heteroaromatic compounds, aromatic compounds, steroids and alkaloids with over 125 new compounds synthesized. Expertise especially in low volume, high value synthesis. We seek opportinuites to use our expertise globally to synthesize novel, difficult to make molecules.
- Repeat and continuing Contract Research and Development projects with major multinational and venture pharmaceutical and biotech companies.
- Production of fine chemicals for Research and chemical supply houses (Aldrich and Sigma).
Our clients are our partners. We will do everything we can to meet your needs with extensive consultation before, during and following each project to ensure that we are proceeding according to your wishes
Greg Brown inducted as a Fellow of the Royal Society of Canada on Nov 20, 2004.
For more further information see press releases
CIDtech Research Inc. 1200 Franklin Blvd. Cambridge, Ontario Canada N1R 6T5 tel: (519) 621-3334, fax: (519) 621-9864